|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Departments of Anesthesiology and Medicine, University of Florida College of Medicine, Gainesville
The recognized incidence of the adult respiratory distress syndrome (ARDS) has increased. While the etiology can be variable, the common denominators are usually an acute loss of pulmonary surfactant and an increase in pulmonary water, which result in a large intrapulmonary right-to-left shunt. Treatment usually consists of continuous positive pressure ventilation (CPPV) and intravenous administration of corticosteroid drugs. With careful management, survival frequently results and arterial oxygenation returns to normal. This report indicates that residual pulmonary damage may persist for many months following ARDS, despite a return to normal arterial oxygenation.
This article has been cited by other articles:
![]() |
T. A. Neff, R. Stocker, H.-R. Frey, S. Stein, and E. W. Russi Long-term Assessment of Lung Function in Survivors of Severe ARDS Chest, March 1, 2003; 123(3): 845 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Herridge, A. M. Cheung, C. M. Tansey, A. Matte-Martyn, N. Diaz-Granados, F. Al-Saidi, A. B. Cooper, C. B. Guest, C. D. Mazer, S. Mehta, et al. One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome N. Engl. J. Med., February 20, 2003; 348(8): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |